Therapeutic Solutions International Inc
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulfora… Read more
Market Cap & Net Worth: Therapeutic Solutions International Inc (TSOI)
Therapeutic Solutions International Inc (PINK:TSOI) has a market capitalization of $1.54 Million ($1.54 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #37462 globally and #12199 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Therapeutic Solutions International Inc's stock price $0.00 by its total outstanding shares 5122705536 (5.12 Billion).
Therapeutic Solutions International Inc Market Cap History: 2015 to 2025
Therapeutic Solutions International Inc's market capitalization history from 2015 to 2025. Data shows change from $20.49 Million to $1.54 Million (-26.61% CAGR).
Therapeutic Solutions International Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Therapeutic Solutions International Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
51.75x
Therapeutic Solutions International Inc's market cap is 51.75 times its annual revenue
2015.79x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $20.49 Million | $268.89K | -$288.75K | 76.20x | N/A |
| 2016 | $19.47 Million | $1.91K | -$586.44K | 10186.44x | N/A |
| 2017 | $36.37 Million | $2.85K | -$995.47K | 12757.35x | N/A |
| 2018 | $28.17 Million | $3.48K | -$1.87 Million | 8086.93x | N/A |
| 2019 | $16.90 Million | $27.50K | -$1.70 Million | 614.84x | N/A |
| 2020 | $32.79 Million | $62.68K | -$2.20 Million | 523.05x | N/A |
| 2021 | $148.56 Million | $145.96K | -$2.96 Million | 1017.83x | N/A |
| 2022 | $30.74 Million | $206.77K | -$3.81 Million | 148.65x | N/A |
| 2023 | $5.12 Million | $98.99K | -$2.17 Million | 51.75x | N/A |
Competitor Companies of TSOI by Market Capitalization
Companies near Therapeutic Solutions International Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Therapeutic Solutions International Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Therapeutic Solutions International Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Therapeutic Solutions International Inc's market cap moved from $20.49 Million to $ 1.54 Million, with a yearly change of -26.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.54 Million | -40.00% |
| 2024 | $2.56 Million | -50.00% |
| 2023 | $5.12 Million | -83.33% |
| 2022 | $30.74 Million | -79.31% |
| 2021 | $148.56 Million | +353.12% |
| 2020 | $32.79 Million | +93.94% |
| 2019 | $16.90 Million | -40.00% |
| 2018 | $28.17 Million | -22.54% |
| 2017 | $36.37 Million | +86.84% |
| 2016 | $19.47 Million | -5.00% |
| 2015 | $20.49 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Therapeutic Solutions International Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.54 Million USD |
| MoneyControl | $1.54 Million USD |
| MarketWatch | $1.54 Million USD |
| marketcap.company | $1.54 Million USD |
| Reuters | $1.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.